![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion p... Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.17 | -11.0065851364 | 10.63 | 11.2 | 9.08 | 601738 | 10.11448905 | CS |
4 | 1.26 | 15.3658536585 | 8.2 | 11.2 | 6.8 | 792837 | 8.45575773 | CS |
12 | 2.96 | 45.5384615385 | 6.5 | 11.2 | 6.43 | 611201 | 8.29871662 | CS |
26 | 5.17 | 120.512820513 | 4.29 | 13.68 | 4.145 | 610195 | 8.92922331 | CS |
52 | 6.23 | 192.879256966 | 3.23 | 13.68 | 2.18 | 389739 | 7.83456406 | CS |
156 | -0.38 | -3.86178861789 | 9.84 | 15.2581 | 1.53 | 238295 | 6.31766148 | CS |
260 | -2.54 | -21.1666666667 | 12 | 25.87 | 1.53 | 194990 | 7.15563236 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions